According to filings with the U.S. Securities and Exchange Commission, Solenic Medical is raising up to $4,000,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, James Lancaster played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Solenic Medical
Solenic Medical, Inc. is a medical device company developing an innovative non-invasive treatment for infected metallic implants in the body. Using technology invented at the University of Texas Southwestern, Solenic is leveraging the unique properties of alternating magnetic fields (AMF) generated by external coils to eradicate biofilm on the surface of medical implants. This non-invasive treatment addresses a major complication of various surgeries such as knee and hip replacements, as well as in trauma related implants such as plates and rods. This is particularly important given an aging population and the rapid increase in the number of these procedures being performed every year.

To learn more about Solenic Medical, visit http://solenic.com/

Contact:
James Lancaster, Chief Executive Officer
479-571-2592
https://www.linkedin.com/in/jylancaster/

SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.